Our data suggest that MED14-HOXA9 is a cryptic recurrent aberration in T/M MPAL, which might indicate an aggressive clinical course and inferior outcome after conventional chemotherapy. The gene discussed is HOXA9; the disease is mixed phenotype acute leukemia.